DD231353A5 - Verfahren zur herstellung neuer 2-(1-imidazolyl)-ethanol-derivate - Google Patents

Verfahren zur herstellung neuer 2-(1-imidazolyl)-ethanol-derivate Download PDF

Info

Publication number
DD231353A5
DD231353A5 DD84270849A DD27084984A DD231353A5 DD 231353 A5 DD231353 A5 DD 231353A5 DD 84270849 A DD84270849 A DD 84270849A DD 27084984 A DD27084984 A DD 27084984A DD 231353 A5 DD231353 A5 DD 231353A5
Authority
DD
German Democratic Republic
Prior art keywords
imidazolyl
pyridyl
ethanol
prepared
general formula
Prior art date
Application number
DD84270849A
Other languages
German (de)
English (en)
Inventor
Gerhard Walther
Claus Schneider
Karl-Heinz Weber
Karin Boeke-Kuhn
Wolf D Bechtel
Original Assignee
�������@������������@��k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �������@������������@��k�� filed Critical �������@������������@��k��
Publication of DD231353A5 publication Critical patent/DD231353A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DD84270849A 1983-12-17 1984-12-14 Verfahren zur herstellung neuer 2-(1-imidazolyl)-ethanol-derivate DD231353A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833345813 DE3345813A1 (de) 1983-12-17 1983-12-17 Neue 2-(1-imidazolyl)-ethanol-derivate

Publications (1)

Publication Number Publication Date
DD231353A5 true DD231353A5 (de) 1985-12-24

Family

ID=6217323

Family Applications (1)

Application Number Title Priority Date Filing Date
DD84270849A DD231353A5 (de) 1983-12-17 1984-12-14 Verfahren zur herstellung neuer 2-(1-imidazolyl)-ethanol-derivate

Country Status (16)

Country Link
EP (1) EP0149115A3 (fi)
JP (1) JPS60146889A (fi)
KR (1) KR850004477A (fi)
AU (1) AU3684584A (fi)
DD (1) DD231353A5 (fi)
DE (1) DE3345813A1 (fi)
DK (1) DK590084A (fi)
ES (2) ES8608509A1 (fi)
FI (1) FI844951L (fi)
GR (1) GR81210B (fi)
HU (1) HUT37140A (fi)
IL (1) IL73832A0 (fi)
NO (1) NO845031L (fi)
PL (1) PL250930A1 (fi)
PT (1) PT79676B (fi)
ZA (1) ZA849745B (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3628545A1 (de) * 1985-09-23 1987-04-23 Hoechst Ag Arylmethylazole und deren salze, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung
DE3707151A1 (de) * 1987-03-06 1988-09-15 Hoechst Ag 1-(1-aryl-2-hydroxy-ethyl)-imidazole und deren salze, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und ihre verwendung
US5049570A (en) * 1990-01-23 1991-09-17 Du Pont Merck Pharmaceutical Company Pyridylphenyl nitrogen heterocycle-substituted carbinols and derivatives thereof with anti-inflammatory activity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081544A (en) * 1975-12-04 1978-03-28 Schering Corporation Certain 2-(alpha(2-pyridyl)-benzyl)imidazolines and derivatives thereof
JPS58150566A (ja) * 1982-03-03 1983-09-07 Yoshitomi Pharmaceut Ind Ltd 新規イミダゾ−ル誘導体

Also Published As

Publication number Publication date
FI844951A0 (fi) 1984-12-14
FI844951L (fi) 1985-06-18
NO845031L (no) 1985-06-18
ES540904A0 (es) 1985-12-01
ES8602756A1 (es) 1985-12-01
ES538600A0 (es) 1986-06-16
DK590084D0 (da) 1984-12-10
EP0149115A2 (de) 1985-07-24
KR850004477A (ko) 1985-07-15
HUT37140A (en) 1985-11-28
JPS60146889A (ja) 1985-08-02
PT79676B (de) 1986-12-10
DK590084A (da) 1985-06-18
ES8608509A1 (es) 1986-06-16
ZA849745B (en) 1986-08-27
GR81210B (en) 1985-04-08
PT79676A (de) 1985-01-01
IL73832A0 (en) 1985-03-31
EP0149115A3 (de) 1987-12-16
AU3684584A (en) 1985-07-04
DE3345813A1 (de) 1985-06-27
PL250930A1 (en) 1985-12-17

Similar Documents

Publication Publication Date Title
DE2105490C3 (de) 1 -Imidazolylketonderivate
DE1940388A1 (de) Neue 1-(beta-Aryl)aethylimidazolderivate,ihre Herstellung und Verwendung
DD148219A5 (de) Verfahren zur herstellung von hydroxyethyl-azolen
EP0005828B1 (de) Neue substituierte Phenylpiperazinderivate, diese enthaltende Arzneimittel und Verfahren zu deren Herstellung
DE3218129A1 (de) Azolylmethyloxirane, ihre herstellung und verwendung als arzneimittel
DE2839388A1 (de) Imidazolylvinylaether und deren verwendung
DD231353A5 (de) Verfahren zur herstellung neuer 2-(1-imidazolyl)-ethanol-derivate
DE2642331A1 (de) Basisch substituierte pyridincarboxamide
DE69500329T2 (de) Neue Triazol-Verbindung mit fungizider Wirkung, deren Herstellung und Verwendung
EP0029505B1 (de) Substituierte 2-Phenylamino-imidazoline-(2), deren Säureadditionssalze, diese enthaltende Arzneimittel und Verfahren zur Herstellung derselben
DE1931027A1 (de) 1-Substituierte-3-Aroylpyrrolidine und Verfahren zu deren Herstellung
DE3042844A1 (de) 2-(1h-imidazol-1-yl)-aethoxyderivate von chinolin-2- und 4-methanolen, verfahren zu ihrer herstellung, arzneimittel und ihre verwendung
EP0158789A1 (de) Diaminderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2934609A1 (de) Tetrahydrochinolinderivate, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende pharmazeutische zubereitungen.
EP0117531B1 (de) N-(3-Trifluormethylphenyl)-N'-propargylpiperazin, seine Herstellung und Verwendung
DE2013793C2 (de) N-Methyl-imidazol-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE3101456A1 (de) Phenylpiperazinyl-propanole von hetarylphenolen, ihre herstellung und diese enthaltende therapeutische mittel
EP0281121B1 (de) 1-(1-Aryl-2-hydroxy-ethyl)-imidazole und deren Salze, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Arzneimittel und ihre Verwendung
DE3876546T2 (de) Ethanon-oxime.
DE3343671A1 (de) Aminopropanolderivate von substituierten 2-hydroxy-propiophenonen, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
EP0004260B1 (de) Substituierte Chinolizidin- und Indolizidinmethanolderivate, Verfahren zur Herstellung derselben und Arzneimittel, welche diese enthalten
DE69114644T2 (de) 4(5)-Imidazole fähig zur Inhibierung von Aromatase.
EP0000479B1 (de) Substituierte 1-Piperazinyl-4H-s-triazolo (3,4-c)thieno(2,3-e)1,4-diazepine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE3146373A1 (de) 2-aminoaethanolverbindungen, verfahren zu ihrer herstellung und pharmazeutische mittel, die diese verbindungen enthalten
DE2016290A1 (de) Substituierte N Hydroxylakyl 2 arylamine) imidazoline (2) und Verfahren zu deren Herstellung